Recently, translational research in the scientific world is a necessity. Effective connection between basic research and clinical application or translation of research results to clinical application requires an excellent strategy. Many aspects that require attention in development of translational research are basic research that leads from targeted therapy to clinical application research with a specific marker from laboratories to individual therapies. Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. Herbal extracts as well as numerous phytochemicals derived from herbal and edible plants have been reported could inhibit carcinogenesis process.  Development of Cancer Chemoprevention Research in conjunction with clinical application needs to be pursued effectively; therefore it can be more beneficial to human welfare, especially in dealing with health problems. The success of several recent clinical trials in preventing cancer in high-risk population suggests that cancer chemoprevention is a rational and appealing strategy.

In the next decade, all technologies will assist to the major aspects of cancer chemoprevention: discovery and characterization of chemopreventive agents; evaluation and validation of carcinogenesis biomarkers as substitute endpoints for cancer effect that are beneficial to evaluate  chemopreventive efficacy; and identification of individual, as well as population-based cancer risks such as clinical trial design and public health impact, for choosing benefiting from chemopreventive strategies and compatible to evaluate these strategies.

Research Centre for Chemistry – LIPI and Indonesian Society for Cancer Chemoprevention (ISCC) in collaboration with Faculty of Pharmacy-Gadjah Mada University, Deutscher Akademischer Austausch Dienst-German Academic Exchange Service (DAAD), Leiden-Amsterdam Center Drug Research (LACDR) Netherland, Nara Instititute of Science and Technology (NAIST) Japan, Korea Institute of Science and Technology (KIST) Korea and JEOL Japan will organize an international seminar ‘TRANSLATIONAL RESEARCH IN CANCER CHEMOPREVENTION’ as well support the development of cancer chemoprevention research association in Indonesia.

For more information about seminar, please go to website: http://iscc2011.org